Centerspace
NYSE:CSRREIT - Residential
-$0.16 today
- Market cap
- $944.16M
- Beta
- 0.89
- P/E (TTM)
- 110.2
- EPS (TTM)
- $0.50
- Dividend yield
- 5.63%
Volume 0.16M
Average 0.15M
CSR Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
CenterspaceNYSE: CSR
Research & Development · Q1 FY2026 · quarter ended Mar 2026
Research & development remains negative
Q1 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Research & Development vs competitors
How CSR compares with its peers on the latest reported figures
- CSR's LTM Mar 2026 research & development of $0 is the highest of the 9 companies compared; the peer median is $0.
- Research & development amounts to 0.0% of revenue for CSR, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | -100.0% | +0.2% | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding CSR) | $0 | -100.0% | +0.2% | 0.0% | |
Competitors are the stored peer set for CSR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 201.71M | 256.72M | 261.31M | 260.98M | 353.13M |
| Cost of Revenue | 90.61M | 118.53M | 115.17M | 112.37M | 342.37M |
| Gross Profit | 111.1M | 138.18M | 146.14M | 148.61M | 10.76M |
| Gross Margin | 55.1% | 53.8% | 55.9% | 56.9% | 3.0% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 16.21M | 17.52M | 20.08M | 17.8M | 20.92M |
| Operating Expenses | 81.2M | 124.32M | 61.69M | 128.14M | (92.31M) |
| Depreciation & Amortization | 93.11M | 106.21M | 103.17M | 107.65M | 113.23M |
| EBITDA | 123M | 121.32M | 188.83M | 130.74M | 180.67M |
| EBITDA Margin | 61.0% | 47.3% | 72.3% | 50.1% | 51.2% |
| Operating Income | 29.89M | 13.86M | 84.45M | 20.48M | 103.07M |
| Operating Margin | 14.8% | 5.4% | 32.3% | 7.8% | 29.2% |
| Interest Income | 0 | 1.25M | 1.21M | 2.61M | 0 |
| Interest Expense | 31.99M | 32.75M | 36.43M | 37.28M | 44.48M |
| Other Income / Expenses | (31.99M) | (31.5M) | (35.22M) | (34.67M) | (80.11M) |
| Income Before Tax | (2.1M) | (17.64M) | 49.23M | (14.19M) | 22.96M |
| Pre-Tax Margin | -1.0% | -6.9% | 18.8% | -5.4% | 6.5% |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Net Income | 611K | (13.47M) | 41.97M | (10.69M) | 17.59M |
| Net Margin | 0.3% | -5.2% | 16.1% | -4.1% | 5.0% |
| EPS (Basic) | (2.27) | (0.99) | 2.65 | (1.27) | 1.02 |
| EPS (Diluted) | (2.00) | (0.99) | 2.32 | (1.27) | 1.02 |
| Weighted Avg Shares | 13.8M | 15.22M | 14.99M | 15.5M | 16.73M |
| Weighted Avg Shares (Diluted) | 15.7M | 15.22M | 17.12M | 15.5M | 16.78M |
Centerspace
NYSE:CSR
Intrinsic Alpha fair value
Locked
Current Price
$56.12
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.